Andrew Witty

Latest stories

3d
Investors Chronicle
New GSK chief - what will be expected of Emma Walmsley?(GSK) has named its current head of consumer healthcare, Emma Walmsley, as its
New GSK chief - what will be expected of Emma Walmsley?
Investors Chronicle / Posted 3 days ago
(GSK) has named its current head of consumer healthcare, Emma Walmsley, as its next chief executive, replacing 'GSK lifer' Andrew Witty at the helm of Britain's biggest pharmaceuticals group. While tabloids have leapt on the fact that she is only... Read more
57 related stories
4d
Breitbart
Bill Clinton Praises the Clinton Global Initiative at Final Annual Meetingbeen investigated by the financial services board for alleged theft of governme
Bill Clinton Praises the Clinton Global Initiative at Final Annual Meeting
Breitbart / Posted 4 days ago
been investigated by the financial services board for alleged theft of government retirement funds, according to reports. Andrew Witty: The CEO of GlaxoSmithKline, a pharmaceutical company accused of failing to immediately make public information... Read more
4d
Zero Hedge
September 21healthcare division receded yesterday when the pharmaceuticals group appointed
September 21
Zero Hedge / Posted 4 days ago
healthcare division receded yesterday when the pharmaceuticals group appointed the head of the division to succeed Sir Andrew Witty as group chief executive. (http://bit.ly/2cHRLsP) Royal Bank of Scotland's sale of a smaller lender to... Read more
9 related stories
5d
Scotsman
Drugs giant GSK names Emma Walmsley as new chief(GSK) has named its consumer healthcare boss Emma Walmsley as chief executive‑d
Drugs giant GSK names Emma Walmsley as new chief
Scotsman / Posted 5 days ago
(GSK) has named its consumer healthcare boss Emma Walmsley as chief executive‑designate to replace Sir Andrew Witty when he steps down next March. She will join a small band of women at the top of the UK’s biggest listed... Read more
5d
TheBull
Glaxo becomes seventh female-led FTSE 100 firmexecutive, a move which will make her the most powerful woman on the FTSE 100.
Glaxo becomes seventh female-led FTSE 100 firm
TheBull / Posted 5 days ago
executive, a move which will make her the most powerful woman on the FTSE 100. The 47-year-old, who succeeds outgoing boss Andrew Witty, will become the seventh female chief executive of a group currently listed on London's benchmark shares... Read more
57 related stories
5d
Times of Malta
GlaxoSmithKline names insider Emma Walmsley as its new CEOBritain’s FTSE 100 index to seven. Walmsley, 47, joined Britain’s biggest drug
GlaxoSmithKline names insider Emma Walmsley as its new CEO
Times of Malta / Posted 5 days ago
Britain’s FTSE 100 index to seven. Walmsley, 47, joined Britain’s biggest drugmaker in 2010 from L’Oreal and will replace Andrew Witty, who had previously announced his decision to retire on March 31, 2017. She will join the board from... Read more
10 related stories
5d
Boston Globe
Glaxo names consumer head Emma Walmsley to succeed Witty as CEOLONDON — GlaxoSmithKline promoted Emma Walmsley to succeed Andrew Witty as chie
Glaxo names consumer head Emma Walmsley to succeed Witty as CEO
Boston Globe / Posted 5 days ago
LONDON — GlaxoSmithKline promoted Emma Walmsley to succeed Andrew Witty as chief executive officer when he retires, singling out Britain’s largest drugmaker as the only major global pharmaceutical company led by a woman. Walmsley currently leads... Read more
57 related stories
5d
Market Watch
GlaxoSmithKline appoints Emma Walmsley next CEOLONDON -- GlaxoSmithKline PLC said its head of consumer health care, Emma Walms
GlaxoSmithKline appoints Emma Walmsley next CEO
Market Watch / Posted 5 days ago
LONDON -- GlaxoSmithKline PLC said its head of consumer health care, Emma Walmsley, will succeed Andrew Witty as chief executive, a move that punctuates the company's growing emphasis on higher-volume, lower-margin drugstore staples such as... Read more
57 related stories
5d
heraldscotland
Sterling hits five-week low amid US and Japanese central bank decision jittersflat after the drugs giant named its consumer healthcare boss Emma Walmsley as
Sterling hits five-week low amid US and Japanese central bank decision jitters
heraldscotland / Posted 5 days ago
flat after the drugs giant named its consumer healthcare boss Emma Walmsley as its new chief executive, replacing Sir Andrew Witty when he retires next March. Glaxo's shares closed lower by 0.5p at 1645p. Away from the top tier index, Sports... Read more
4 related stories
5d
Calcutta News
Drugmaker GlaxoSmithKline decides on Emma Walmsley to replace CEO Andrew Witty in 2017 LONDON, U.K. - Leading British drugmaker GlaxoSmithKline has decided to repla
Drugmaker GlaxoSmithKline decides on Emma Walmsley to replace CEO Andrew Witty in 2017
Calcutta News / Posted 5 days ago
LONDON, U.K. - Leading British drugmaker GlaxoSmithKline has decided to replace CEO Andrew Witty with Emma Walmsley early next year when Witty retires. With... Read more
10 related stories
5d
Belfast Telegraph
Sterling hits five-week low amid US and Japanese central bank decision jittersflat after the drugs giant names its consumer healthcare boss Emma Walmsley as
Sterling hits five-week low amid US and Japanese central bank decision jitters
Belfast Telegraph / Posted 5 days ago
flat after the drugs giant names its consumer healthcare boss Emma Walmsley as its new chief executive, replacing Sir Andrew Witty when he retires next March. Glaxo's shares closed lower by 0.5p at 1645p. Away from the top tier index, Sports... Read more
5d
Fortune
GlaxoSmithKline’s Emma Walmsley Just Became Britain’s Most Powerful Businesswomanhead of consumer healthcare, would become its next CEO. The company said on Tu
GlaxoSmithKline’s Emma Walmsley Just Became Britain’s Most Powerful Businesswoman
Fortune / Posted 5 days ago
head of consumer healthcare, would become its next CEO. The company said on Tuesday that Walmsley, 47, will take over for Andrew Witty, who previously said he would retire in March 2017. Walmsley, who joined GSK in 2010 after 17 years at L’Oreal,... Read more
5d
Aljazeera
Superbugs reach apex of global health worriesget elevated to the top of the global agenda, with World Bank President Jim Yon
Superbugs reach apex of global health worries
Aljazeera / Posted 5 days ago
get elevated to the top of the global agenda, with World Bank President Jim Yong Kim, GlaxoSmithKline drug firm boss Sir Andrew Witty, and others meeting at the United Nations to keep antibiotics and other drugs working for future... Read more
5d
International Business Times
GlaxoSmithKline's new boss: Who is Emma Walmsley?the most powerful female chief executive in the UK. When she takes over at drug
GlaxoSmithKline's new boss: Who is Emma Walmsley?
International Business Times / Posted 5 days ago
the most powerful female chief executive in the UK. When she takes over at drugs giant GlaxoSmithKline (GSK) from Sir Andrew Witty next April, she will head the largest firm of the seven women running FTSE 100 firms. There are other female... Read more
57 related stories
5d
The Irish Times
GlaxoSmithKline appoints Walmsley as chief executive Walmsley will succeed Andrew Witty when he retires Emma Walmsley: she will j
GlaxoSmithKline appoints Walmsley as chief executive
The Irish Times / Posted 5 days ago
Walmsley will succeed Andrew Witty when he retires Emma Walmsley: she will join the board on January 1st, and take the helm of the company on March 31st Walmsley is currently the head of the... Read more
57 related stories
5d
Market Watch
GlaxoSmithKline names first female CEOLONDON-- GlaxoSmithKline PLC said its head of consumer health care, Emma Walmsl
GlaxoSmithKline names first female CEO
Market Watch / Posted 5 days ago
LONDON-- GlaxoSmithKline PLC said its head of consumer health care, Emma Walmsley, will succeed Andrew Witty as chief executive, in a move that cements the company's shift away from its dominant prescription-medicine business. Ms. Walmsley, 47 years... Read more
57 related stories
5d
BBC News
GlaxoSmithKline names Emma Walmsley as chief executivechief executive. Ms Walmsley, who joined the UK's biggest drugmaker in 2010 fr
GlaxoSmithKline names Emma Walmsley as chief executive
BBC News / Posted 5 days ago
chief executive. Ms Walmsley, who joined the UK's biggest drugmaker in 2010 from L'Oreal, will replace current chief Sir Andrew Witty in March 2017. Ms Walmsley describes herself as "extremely competitive" with "a bit of a bias for action". She... Read more
57 related stories
5d
Quartz
The danger of sales commission plans that work too wellsystem was time-consuming and clunky, and investors questioned whether it was c
The danger of sales commission plans that work too well
Quartz / Posted 5 days ago
system was time-consuming and clunky, and investors questioned whether it was costing the slumping company revenue. But CEO Andrew Witty argued it was better to make the reforms voluntarily before they were forced onto the industry. Wells Fargo is... Read more
5d
Swissinfo
Glaxo's New CEO Ticks All But One Box. Science Is Optional: GadflyThe appointment ticks all but one box. The U.K. pharmaceuticals group has been
Glaxo's New CEO Ticks All But One Box. Science Is Optional: Gadfly
Swissinfo / Posted 5 days ago
The appointment ticks all but one box. The U.K. pharmaceuticals group has been hunting in earnest for a new leader since Andrew Witty announced his retirement in March amid investor grumbling at the company's poor share performance. It's since... Read more
57 related stories
5d
North-West Evening Mail
GSK announces new chief executiveDrugs giant GlaxoSmithKline has named its new chief executive to replace Sir An
GSK announces new chief executive
North-West Evening Mail / Posted 5 days ago
Drugs giant GlaxoSmithKline has named its new chief executive to replace Sir Andrew Witty. Sir Andrew is retiring this coming March and will be succeeded by Emma Walmsley, who has previously helmed GSK’s £6 billion consumer healthcare... Read more
57 related stories
5d
Gazette
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Gazette / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
guardian-series
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
guardian-series / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Greenock Telegraph
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Greenock Telegraph / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Harrow Times
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Harrow Times / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
This is West Country
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
This is West Country / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Gazette News
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Gazette News / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Bolton News
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Bolton News / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Belfast Telegraph
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Belfast Telegraph / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
St Albans & Harpenden Review
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
St Albans & Harpenden Review / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Wandsworth Guardian
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Wandsworth Guardian / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
EveningTimes Online
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
EveningTimes Online / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Croydon Guardian
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Croydon Guardian / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Hampshire Chronicle
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Hampshire Chronicle / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
This is Oxfordshire
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
This is Oxfordshire / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Lancashire Telegraph
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Lancashire Telegraph / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
The News and Star
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
The News and Star / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
West Moreland Gazette
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
West Moreland Gazette / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Kingston Guardian
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Kingston Guardian / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Oxford Mail
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Oxford Mail / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
Bury Times
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executiveWalmsley has been promoted from heading Glaxo's consumer healthcare arm to chie
Emma Walmsley set to be FTSE 100's most powerful woman as Glaxo chief executive
Bury Times / Posted 5 days ago
Walmsley has been promoted from heading Glaxo's consumer healthcare arm to chief executive designate and will replace Sir Andrew Witty when he retires next March. She will join a small band of women at the top of some of the UK's biggest listed... Read more
57 related stories
5d
The Globe and Mail
GlaxoSmithKline names insider Emma Walmsley as new CEOin Britain’s FTSE 100 index. Walmsley, 47, joined Britain’s biggest drug maker
GlaxoSmithKline names insider Emma Walmsley as new CEO
The Globe and Mail / Posted 5 days ago
in Britain’s FTSE 100 index. Walmsley, 47, joined Britain’s biggest drug maker in 2010 from L’Oreal and will replace Andrew Witty, who had previously announced his decision to retire on March 31, 2017. She will join the board from... Read more
10 related stories
5d
CNBC
Wall Street seen higher ahead of Fed meeting and housing starts; oil lowerand earnings in forthcoming years after announcing a planned $66 billion takeov
Wall Street seen higher ahead of Fed meeting and housing starts; oil lower
CNBC / Posted 5 days ago
and earnings in forthcoming years after announcing a planned $66 billion takeover of Monsanto. London-listed shares of GSK were 0.6 percent lower after the company said Emma Walmsley would replace Andrew Witty as CEO when he retires in March... Read more
5d
Manila Bulletin
GlaxoSmithKline names insider Emma Walmsley as new CEOBritain’s FTSE 100 index. Walmsley, 47, joined Britain’s biggest drugmaker in
GlaxoSmithKline names insider Emma Walmsley as new CEO
Manila Bulletin / Posted 5 days ago
Britain’s FTSE 100 index. Walmsley, 47, joined Britain’s biggest drugmaker in 2010 from L’Oreal (OREP.PA) and will replace Andrew Witty, who had previously announced his decision to retire on March 31, 2017. She will join the board from... Read more
10 related stories
5d
Channel NewsAsia
GlaxoSmithKline names insider Emma Walmsley as new CEOin Britain's FTSE 100 index. Walmsley, 47, joined Britain's biggest drugmaker
GlaxoSmithKline names insider Emma Walmsley as new CEO
Channel NewsAsia / Posted 5 days ago
in Britain's FTSE 100 index. Walmsley, 47, joined Britain's biggest drugmaker in 2010 from L’Oreal and will replace Andrew Witty, who had previously announced his decision to retire on March 31, 2017. She will join the board from... Read more
57 related stories
5d
Market Watch
GlaxoSmithKline names Emma Walmsley as next CEOLONDON-- GlaxoSmithKline PLC said its head of consumer health-care, Emma Walmsl
GlaxoSmithKline names Emma Walmsley as next CEO
Market Watch / Posted 5 days ago
LONDON-- GlaxoSmithKline PLC said its head of consumer health-care, Emma Walmsley, will succeed Andrew Witty as chief executive. Ms Walmsley, 47, will take up the post when Mr. Witty steps down on March 31, making Glaxo the only large pharmaceutical... Read more
57 related stories
5d
Business Standard India
GlaxoSmithKline picks insider Emma Walmsley as new CEOinternal and external candidates. Walmsley, who joined Britain's biggest drugm
GlaxoSmithKline picks insider Emma Walmsley as new CEO
Business Standard India / Posted 5 days ago
internal and external candidates. Walmsley, who joined Britain's biggest drugmaker in 2010 from L'Oreal, will replace Andrew Witty who had previously announced his decision to retire on March 31, 2017. The decision will disappoint investors... Read more
10 related stories
5d
iol.co.za
GlaxoSmithKline names insider as new CEOWalmsley, 47, joined Britain's biggest drugmaker in 2010 from L'Oreal and will
GlaxoSmithKline names insider as new CEO
iol.co.za / Posted 5 days ago
Walmsley, 47, joined Britain's biggest drugmaker in 2010 from L'Oreal and will replace Andrew Witty, who had previously announced his decision to retire on March 31, 2017. She will join the board from January. The decision will disappoint investors... Read more
57 related stories
5d
Reuters
GlaxoSmithKline names insider Emma Walmsley as new CEOBritain's FTSE 100 index. Walmsley, 47, joined Britain's biggest drugmaker in
GlaxoSmithKline names insider Emma Walmsley as new CEO
Reuters / Posted 5 days ago
Britain's FTSE 100 index. Walmsley, 47, joined Britain's biggest drugmaker in 2010 from L’Oreal (OREP.PA) and will replace Andrew Witty, who had previously announced his decision to retire on March 31, 2017. She will join the board from... Read more
57 related stories
5d
FOX Business
Glaxosmithkline Names Walmsley New Ceointernal and external candidates. Walmsley, who joined Britain's biggest drugm
Glaxosmithkline Names Walmsley New Ceo
FOX Business / Posted 5 days ago
internal and external candidates. Walmsley, who joined Britain's biggest drugmaker in 2010 from L'Oreal, will replace Andrew Witty who had previously announced his decision to retire on March 31, 2017. (Reporting by Ben Hirschler, editing by... Read more
10 related stories
5d
FOX Business
Glaxosmithkline Names Walmsley New Ceocandidates. Continue Reading Below Walmsley, who joined Britain's biggest dru
Glaxosmithkline Names Walmsley New Ceo
FOX Business / Posted 5 days ago
candidates. Continue Reading Below Walmsley, who joined Britain's biggest drugmaker in 2010 from L'Oreal, will replace Andrew Witty who had previously announced his decision to retire on March 31, 2017. (Reporting by Ben Hirschler, editing by... Read more
10 related stories
More

People in this news